A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...

Contineum Therapeutics (CTNM) shares fell following the results from its mid-stage trial of PIPE-307, a treatment aimed at ...

“Identifying the causes and risk factors of MS and substantiating the effectiveness of certain interventions are both crucial ...

Contineum Therapeutics’ M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis. | Contineum Therapeutics’ M1 receptor ...

Roche Holding AG said a multiple sclerosis drug showed it could work for most forms of the disease in two late-stage trials, ...

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...

An insurance company repeatedly denied a Wisconsin woman coverage for a medication her doctor prescribed to treat her ...

A clinical trial testing an experimental vaccine for the Epstein-Barr virus (EBV) in people with MS is now recruiting ...

Selma Blair shared an update on her battle with multiple sclerosis (MS), more than seven years after revealing her diagnosis.

Selma Blair exclusively told PEOPLE that she feels like she’s getting her stamina back amid her journey with multiple ...

Selma Blair shared an update on her multiple sclerosis (MS) after being diagnosed with the autoimmune disease in 2018, while ...

Guest writer Shara Sand says that her severe mood changes went unidentified until a psychiatrist diagnosed her with bipolar ...